This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

Inventage Lab Inc


Inventage Lab is a DDS (Drug Delivery System) platform company that possesses the IVL-DrugFluidic® platform, which integrates Microfluidics into pharmaceutical research and development and mass production of long-acting injectables, and the IVL-GeneFluidic® platform that is applied for the drug delivery of genetic materials.IVL-DrugFluidic® is designed to eliminate the known drawbacks of traditional microsphere-based long-acting injectables and maximize the quality of long-acting injectables. We out-licensed our in-house projects to a global animal drug company and domestic top-tiered pharmaceutical companies. We succeeded in the Phase 1/2 study for IVL3001(finasteride LAI for androgenic alopecia) in Australia and are preparing for the Phase 3 study next year.With IVL-GeneFluidic®, we provide CDMO services from LNP Formulation to manufacturing clinical samples and commercial products for gene therapies/mRNA vaccines and treatment. Through our in-house research on developing long-acting injectable platforms, we have leveraged our knowledge in microfluidics process engineering and optimized it for the LNP field. We have established an LNP production line in an EU-GMP grade facility and actively provide CDMO services.